Vaccine developers can't keep up with COVID's mutations
In April, the U.S. Food and Drug Administration and the Centers for Disease Control and Prevention both updated their recommendations for COVID vaccines, providing more flexibility for higher-risk individuals who want additional protection from the SARS-CoV-2 virus that causes COVID-19. The bivalent vaccines may not stand up very well against these new strains, which are evolving so fast that some experts even argue that we should rename the virus SARS-CoV-3 to emphasize its distant genetic drift from the original pathogen. Yet another study, this one published in the peer-reviewed journal Clinical Infectious Diseases on April 10, reported data from a randomized clinical trial; ominously, the study authors emphasized an "ongoing concern that the breadth of antibody response from current updated vaccines is not optimal for the pace of virus evolution." In other words, the bivalent vaccines may not stand up very well against these new strains, which are evolving so fast that some experts even argue that we should rename the virus SARS-CoV-3 to emphasize its distant genetic drift from the original pathogen. But while the bivalent vaccines may be unlikely to prevent infection against the currently circulating strains in North America, it's worth repeating that they will still stop severe illness and death.




















FDA vaccine adviser says healthy young people SHOULDN'T get another COVID booster











Discover Related

The CDC buried a measles forecast that stressed the need for vaccinations

A bad omen for public trust in vaccines

After Covid, is the world well prepared for another pandemic?

Fears of U.S. public health crises grow amid falling vaccination rates

More people are currently dying from the flu in California than from Covid

Advances in vaccine technology and the road ahead

Tuberculosis is on the rise again. We can fight it — if we try

Opinion: Long COVID is solvable, but we need more clinical trials

Govt to collate journey of U-WIN so far to overcome challenges

Covid-19 pandemic fueled vaccine misinformation – What experts are saying

Bird flu mutating very fast: Health experts warn after first human death in US

Common COVID-19 Symptoms Doctors Are Seeing In Winter 2025

The mystery of why Covid-19 seems to be becoming milder

5 things we know and still don’t know about COVID, 5 years after it appeared

Bird flu virus shows mutations in first severe human case in U.S., CDC says

There’s Still Time to Get Ahead of the Next Global Pandemic

How America lost control of bird flu, setting the stage for another pandemic

How America lost control of the bird flu, setting the stage for another pandemic

Patients are frustrated that there isn't a reliable treatment yet for long COVID

GOP senator: 'Everybody here has lost someone' — possibly from the COVID vaccine

Sudden deaths among youth not linked to Covid vaccines, JP Nadda tells Parliament
